MX352040B - Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas. - Google Patents

Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas.

Info

Publication number
MX352040B
MX352040B MX2013007679A MX2013007679A MX352040B MX 352040 B MX352040 B MX 352040B MX 2013007679 A MX2013007679 A MX 2013007679A MX 2013007679 A MX2013007679 A MX 2013007679A MX 352040 B MX352040 B MX 352040B
Authority
MX
Mexico
Prior art keywords
fatty acids
long chain
including human
human milk
polyunsaturated
Prior art date
Application number
MX2013007679A
Other languages
English (en)
Other versions
MX2013007679A (es
Inventor
O Duska-Mcewen Geralyn
P Schaller Joseph
Buck Rachael
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2013007679A publication Critical patent/MX2013007679A/es
Publication of MX352040B publication Critical patent/MX352040B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/186—Fatty acids
    • A23V2250/1882—Polyunsaturated fatty acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)

Abstract

La presente invención se refiere a las composiciones nutricionales que incluyen los oligosacáridos de leche humana en combinación con los ácidos grasos poliinsaturados de cadena larga y/o con los carotenoides que se pueden administrar a los bebés prematuros, a los bebés nacidos a término, a los infantes, y a los niños para reducir la inflamación y la incidencia de enfermedades inflamatorias.
MX2013007679A 2010-12-31 2011-12-22 Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas. MX352040B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061428861P 2010-12-31 2010-12-31
PCT/US2011/067022 WO2012092157A2 (en) 2010-12-31 2011-12-22 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

Publications (2)

Publication Number Publication Date
MX2013007679A MX2013007679A (es) 2013-09-26
MX352040B true MX352040B (es) 2017-11-07

Family

ID=45496314

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007679A MX352040B (es) 2010-12-31 2011-12-22 Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas.

Country Status (10)

Country Link
US (17) US8703737B2 (es)
EP (1) EP2658400A2 (es)
CN (2) CN108420076A (es)
BR (1) BR112013016587A2 (es)
CA (1) CA2822664C (es)
MX (1) MX352040B (es)
MY (2) MY192208A (es)
NZ (1) NZ613165A (es)
SG (1) SG191799A1 (es)
WO (1) WO2012092157A2 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3473257A1 (en) 2010-12-31 2019-04-24 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
NZ611807A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
CA2822497C (en) 2010-12-31 2020-07-28 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
MX352040B (es) 2010-12-31 2017-11-07 Abbott Lab Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas.
CN110051676A (zh) 2010-12-31 2019-07-26 雅培制药有限公司 用于调节炎症的人乳寡糖
EP3510873A1 (en) 2010-12-31 2019-07-17 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
DK2734210T3 (en) 2011-07-22 2018-01-22 Abbott Lab GALACTOOLIGOSACCHARIDES FOR THE PREVENTION OF DAMAGE TO AND / OR PROMOTION OF HEALING OF THE MAVE GAS CHANNEL
BR112014004772A2 (pt) 2011-08-29 2017-03-21 Abbott Lab oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal
MY168661A (en) * 2012-03-27 2018-11-28 Abbott Lab Methods for modulating cell-mediated immunity using human milk oligosaccharides
ES2572831T3 (es) 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
EP2708147B1 (en) * 2012-09-14 2020-03-11 Abbott Laboratories Methods for increasing brain functionality using 2-fucosyl-lactose
WO2014100191A1 (en) * 2012-12-18 2014-06-26 Abbott Laboratories Nutritional compositions comprising neuroprotective dietary oligosaccharides
EP2934190B1 (en) 2012-12-20 2018-12-12 Abbott Laboratories Nutritional formulations using human milk oligosaccharides for modulating inflammation
WO2015077233A1 (en) 2013-11-19 2015-05-28 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
MX2016013064A (es) * 2014-04-08 2017-01-26 Abbott Lab Metodos para mejorar las respuestas inmune innata y/o deteccion de patogenos de la mucosa mediante oligosacaridos de la leche humana.
EP3212198B1 (en) * 2014-10-29 2020-12-23 Glycom A/S Synthetic composition and method for promoting mucosal healing
EP3264923B1 (en) 2015-03-05 2023-01-11 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of gastrointestinal infections in infants or young children
WO2017103850A1 (en) * 2015-12-15 2017-06-22 Glycom A/S Mixture of hmos
WO2017156548A1 (en) * 2016-03-11 2017-09-14 Evolve Biosystems Inc. Food compositions for weaning
CA3030022A1 (en) 2016-07-06 2018-01-11 Building Block Nutritionals, Llc Nutritional formula
IL271112B2 (en) 2017-06-21 2023-11-01 Abbott Lab Methods to increase the growth of beneficial bacteria in the digestive system
EP3743078A4 (en) * 2017-12-22 2022-01-19 Glycom A/S COMPOSITION WITH HMOs TO PREVENT OR REDUCE NOCICEPTION
WO2020108915A1 (en) * 2018-11-30 2020-06-04 Societe Des Produits Nestle S.A. Infant nutritional composition for use in the enhancement of pancreatic maturation and insulin biosynthesis
US12070044B2 (en) 2019-02-22 2024-08-27 Aquero Canada Ltd. Fortified milk compositions and their processes of preparation
CN110038020A (zh) * 2019-04-23 2019-07-23 河南省农业科学院 唾液酸模拟物在制备抑制巨噬细胞感染或激活状态下所引起炎症的药物中的应用
US20220079962A1 (en) 2019-06-04 2022-03-17 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and dietary butyrate
US12005083B1 (en) 2019-06-24 2024-06-11 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
US11849747B1 (en) 2019-06-24 2023-12-26 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
WO2021123377A1 (en) * 2019-12-20 2021-06-24 Basf Se Composition for the treatment of inflammation and/or associated morbidities thereto
IL273038B (en) 2020-03-03 2022-02-01 Ben Zion Karmon bone graft
CN111838475A (zh) * 2020-05-26 2020-10-30 中国科学院合肥物质科学研究院 一种含n-乙酰神经氨酸的胶状体食品及其制备方法
US11606966B2 (en) 2020-06-15 2023-03-21 Building Block Nutritionals, Llc Nutritional formula
CN116847854A (zh) 2020-12-11 2023-10-03 高级蛋白质技术公司 包含岩藻糖基乳糖作为有效成分的抗病毒组合物
WO2022226311A1 (en) * 2021-04-23 2022-10-27 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function
CN113273695B (zh) * 2021-06-03 2022-05-17 海普诺凯营养品有限公司 一种改善新生儿溶血性高胆红素血症的组合物
KR20240141784A (ko) 2022-01-25 2024-09-27 디에스엠 아이피 어셋츠 비.브이. 다중불포화 지방산 생산을 증가시키기 위한 배지 조정 및 영양소 공급 접근법

Family Cites Families (117)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762822A (en) 1985-08-08 1988-08-09 Ettinger Anna C Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides
ES2007350A6 (es) 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
DE3838091A1 (de) 1988-11-10 1990-05-17 Hoechst Ag Kationisch modifizierte novolake, verfahren zu ihrer herstellung und ihre verwendung
US5260280A (en) 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
SE468536B (sv) 1991-07-03 1993-02-01 Bolin Mauritz Ingf Ab Stickkontakt
US5492899A (en) 1994-01-10 1996-02-20 Abbott Laboratories Infant nutritional formula with ribo-nucleotides
MX198456B (es) 1994-03-09 2000-09-05 Abbott Lab Animales trangenicos que producen oligosacaridos y glucoconjugados.
EP0727216B1 (en) 1994-07-15 2003-05-28 TAIYO KAGAKU Co., LTD. Medicinal composition containing sialic acid derivative
JPH08266255A (ja) 1995-03-30 1996-10-15 Taiyo Kagaku Co Ltd 学習能力向上組成物
WO1997048388A1 (en) 1996-06-17 1997-12-24 The Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
JP3552856B2 (ja) 1996-09-27 2004-08-11 雪印乳業株式会社 栄養強化組成物
DE19701382A1 (de) 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US6080787A (en) 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
ES2219871T3 (es) * 1997-02-21 2004-12-01 Abbott Laboratories Procedimiento y composiciones que sirven para limitar la frecuencia de la enterocolitis necrotizante del recien nacido.
SA98190002B1 (ar) 1997-03-28 2006-06-20 ذي يونيفيرسيتي اوف تننيسي ريسيرش كوربوريشن استخدام أحماض دهنية تحتوي على عدة روابط غير مشبعة polyunsaturated fatty acids لتقليل حدوث الالتهاب المعوي القولوني الناخر incidence of necrotizing enterocolitis
US5906982A (en) 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
US6045854A (en) 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
JPH10327804A (ja) 1997-06-04 1998-12-15 Meiji Milk Prod Co Ltd 核酸関連物質、ｄｈａ、アラキドン酸及び コレステロール含有栄養組成物
US20020019991A1 (en) 1998-04-30 2002-02-14 Abbott Laboratories Compositions containing an alpha 1,2-fucose linkage and uses thereof
US6497908B1 (en) 1999-07-19 2002-12-24 Seiri Oshiro Turmeric-containing cooking oils and fats
DE19958985A1 (de) 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
PT1255449E (pt) 2000-02-17 2007-08-24 Wyeth Corp Formulação nutricional contendo substâncias pré-bióticas
US6630452B2 (en) 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
WO2001078748A2 (en) 2000-04-14 2001-10-25 President And Fellows Of Harvard College Immunomodulatory methods using carbohydrate antigens
US6511696B2 (en) 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
US7090862B2 (en) 2001-03-30 2006-08-15 Abbott Laboratories Method of improving the antioxidant status of an infant
AU2002320251A1 (en) 2001-07-05 2003-01-21 Vital Basics, Inc. Compositions for improving mental performance
DE10147100A1 (de) 2001-09-25 2003-04-17 Numico Res B V Antiinfektive Kohlenhydrate
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
DE10204000A1 (de) 2002-02-01 2003-08-14 Nutricia Nv Sialysierte Kohlenhydrate
EP1332759B1 (en) 2002-02-04 2005-09-28 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical and nutritional compositions containing a di- or oligosaccharide as insulin secretion promoter
ES2213441B1 (es) 2002-02-19 2005-05-16 Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria (Inia) Metodo para determinar la contaminacion medioambiental mediante la deteccion de enterovirus bovino (evb) o porcino (evp).
AR039170A1 (es) 2002-03-28 2005-02-09 Bio Dar Ltd Co-granulos de dha y romero y metodos de uso
US20040001817A1 (en) 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
US20040047866A1 (en) 2002-09-09 2004-03-11 President And Fellows Of Harvard College Immunomodulatory methods using carbohydrate antigens
BR0315209A (pt) * 2002-10-11 2005-08-16 Wyeth Corp Formulações nutritivas que contêm substâncias simbióticas
US7008496B2 (en) * 2002-12-16 2006-03-07 Kimberly-Clark Worldwide, Inc. One-step necked-bonded laminate process and apparatus
US20040191295A1 (en) 2003-03-28 2004-09-30 Locniskar Mary Frances Composition and method for viral inhibition
US7867541B2 (en) 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
US7951410B2 (en) 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
US20040214791A1 (en) * 2003-04-25 2004-10-28 Nancy Auestad High lactose infant nutrition formula
ES2416287T3 (es) 2003-06-23 2013-07-31 Nestec S.A. Empleo de una fórmula nutritiva para la función óptima de la barrera intestinal
EP1643862A1 (en) 2003-06-24 2006-04-12 University of Kansas Medical Center Infant formula
EP1682547B1 (en) 2003-10-30 2012-10-24 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors
CA2548140A1 (en) 2003-12-05 2005-06-23 University Of Massachusetts Oligosaccharide compositions and use thereof in the treatment of infection
US20060039954A1 (en) 2003-12-23 2006-02-23 Gierhart Dennis L Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages
US7416752B2 (en) 2004-01-06 2008-08-26 Sharp Ingrained Functional Foods, Inc. Method of fortifying seeds with an essential fatty acid, fortified seed and food product
US7851451B2 (en) 2004-03-12 2010-12-14 Mti Meta Tech Inc. Formulations for mediating inflammatory bowel disorders
US7090879B2 (en) * 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
US7955834B2 (en) 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
EP1721611A1 (en) 2005-04-21 2006-11-15 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
EP1634599A1 (en) 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
ATE361101T1 (de) 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
US20060088574A1 (en) 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
US20060270739A1 (en) 2005-04-28 2006-11-30 Trustees Of Tufts College Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation
US20060246146A1 (en) 2005-04-29 2006-11-02 Mcmahon Robert J Method of increasing the salivary sialic acid content in a mammal
US20060247153A1 (en) 2005-04-29 2006-11-02 Mcmahon Robert J Method of improving learning and memory in mammals
US9179702B2 (en) 2005-07-13 2015-11-10 Abbott Laboratories Liquid nutritional compositions containing unsaturated fatty acids
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US7829126B2 (en) 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
AU2006310880B2 (en) 2005-11-04 2012-06-28 Arla Foods Amba A concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof
EP1981526A4 (en) 2006-01-09 2011-03-02 Childrens Hosp Medical Center ADIPONECTIN FOR THE TREATMENT OF VARIOUS DISORDERS
WO2007084769A2 (en) 2006-01-19 2007-07-26 Solazyme, Inc. Microalgae-derived compositions for improving the health and appearance of skin
RU2448720C2 (ru) 2006-03-07 2012-04-27 Нестек С.А. Синбиотическая смесь
NZ571158A (en) 2006-03-10 2011-08-26 Nutricia Nv Use of non-digestible saccharides administered to a pregnant woman for giving an infant the best start after birth
RU2420210C2 (ru) 2006-03-23 2011-06-10 Нестек С.А. Высококалорийная питательная добавка
WO2007114683A1 (en) 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
US20080003329A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
DK2164349T3 (en) 2006-08-04 2014-12-15 Shs Int Ltd protein-FORMULA
EP1911457A1 (en) 2006-10-12 2008-04-16 N.V. Nutricia Composition to treat or prevent gastrointestinal infection
US20080089981A1 (en) 2006-10-17 2008-04-17 N.V. Nutricia Ketogenic diet
NL1032840C2 (nl) 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
NL1033521C2 (nl) 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
EP2117355B1 (en) 2007-03-13 2017-04-26 N.V. Nutricia Method of improving skills with a composition comprising non-digestible saccharide
NL1033698C2 (nl) 2007-04-16 2008-10-20 Friesland Brands Bv Functioneel serumeiwitproduct voor toepassing in kindervoeding en therapeutische samenstellingen, en werkwijzen ter bereiding daarvan.
JP2010524844A (ja) 2007-04-26 2010-07-22 エーザイ・アール・アンド・ディー・マネジメント株式会社 認知症のためのシンナミド化合物
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
WO2008153377A1 (en) 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
CN101855554B (zh) 2007-09-07 2014-05-14 儿童医院医学中心 分泌者、Lewis和唾液酸化抗原水平作为疾病预测指标的用途
US10251899B2 (en) 2007-10-08 2019-04-09 Mead Johnson Nutrition Company Method for improving stool characteristics in infants
US20090118229A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
SG185948A1 (en) 2007-11-08 2012-12-28 Nestec Sa Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
WO2009067000A1 (en) 2007-11-20 2009-05-28 N.V. Nutricia Composition with synbiotics
WO2009079353A1 (en) 2007-12-14 2009-06-25 Enanta Pharmaceuticals, Inc. Triazole-containing macrocyclic hcv serine protease inhibitors
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
CN101233874B (zh) * 2008-02-02 2010-12-01 内蒙古蒙牛乳业（集团）股份有限公司 一种适用于12-36个月的婴儿液态乳
WO2009102193A1 (en) 2008-02-12 2009-08-20 N.V. Nutricia A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants
NL2001377C2 (nl) 2008-03-14 2009-09-15 Friesland Brands Bv Werkwijze voor het isoleren van siaalzuur bevattende oligosachariden, alsmede de hiermee verkrijgbare siaalzuur bevattende oligosachariden bevatttende samenstellingen.
PT2265135T (pt) 2008-03-14 2018-02-21 Nestec Sa Mistura simbiótica
EP2143341A1 (en) 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
WO2010023178A1 (en) 2008-08-28 2010-03-04 Chr. Hansen A/S Pharmaceuticals comprising a bacterial polysaccharide
EP2379708B1 (en) 2008-12-19 2016-04-27 Jennewein Biotechnologie GmbH Synthesis of fucosylated compounds
CN101449708B (zh) 2008-12-29 2011-08-10 山东龙力生物科技股份有限公司 一种添加合生元的婴幼儿奶粉及其制备方法
UY32443A (es) 2009-02-13 2010-09-30 Sanofi Aventis Nuevos tetrahidronaftalenos, procesos para su preparación y uso de los mismos como medicamento.
ES2458817T5 (es) 2009-03-02 2017-09-11 Roquette Freres Polvo granulado de leche vegetal, procedimiento de obtención de leche vegetal y sus utilizaciones
WO2010115934A1 (en) 2009-04-07 2010-10-14 Glycom A/S Synthesis of 2'-o-fucosyllactose
TWI381845B (zh) 2009-05-21 2013-01-11 Univ Nat Taiwan 預防和治療幽門螺旋桿菌感染的組成物
EP2451462B1 (en) 2009-07-06 2017-09-06 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
WO2011008087A1 (en) 2009-07-15 2011-01-20 N.V. Nutricia Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
CN102481323A (zh) 2009-07-31 2012-05-30 雀巢产品技术援助有限公司 含有益生菌和所选营养物的用于母乳喂养的婴幼儿或宠物的营养组合物
EP2525811B2 (en) 2010-01-19 2019-02-27 Abbott Laboratories A composition comprising lactobacillus rhamnosus hn001 and prebiotics for use in the treatment of allergic lung disease
NL2004201C2 (en) 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides to modulate the immune system.
WO2011122937A1 (en) 2010-03-29 2011-10-06 N.V. Nutricia Pea protein peptides with anti helicobacter pylori activity
WO2011136647A1 (en) 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant and toddler nutrition
WO2011136636A1 (en) 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant nutrition
EP3369739A1 (en) 2010-07-12 2018-09-05 The Regents of The University of California Bovine milk oligosaccharides
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465509A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
EP3510873A1 (en) 2010-12-31 2019-07-17 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
EP3473257A1 (en) 2010-12-31 2019-04-24 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
MX352040B (es) 2010-12-31 2017-11-07 Abbott Lab Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas.
CN110051676A (zh) 2010-12-31 2019-07-26 雅培制药有限公司 用于调节炎症的人乳寡糖
EP2522232A1 (en) 2011-05-13 2012-11-14 Nestec S.A. Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof

Also Published As

Publication number Publication date
BR112013016587A2 (pt) 2016-09-27
US10973837B2 (en) 2021-04-13
US20140256674A1 (en) 2014-09-11
US10369164B2 (en) 2019-08-06
US11524018B2 (en) 2022-12-13
US20230255991A1 (en) 2023-08-17
US20180161354A1 (en) 2018-06-14
US20180161352A1 (en) 2018-06-14
CA2822664C (en) 2021-07-20
US20230149434A1 (en) 2023-05-18
US20200022996A1 (en) 2020-01-23
US9808474B2 (en) 2017-11-07
US20180161351A1 (en) 2018-06-14
MX2013007679A (es) 2013-09-26
US20180104267A1 (en) 2018-04-19
US20180161353A1 (en) 2018-06-14
NZ613165A (en) 2015-02-27
US20180140622A1 (en) 2018-05-24
SG191799A1 (en) 2013-08-30
CA2822664A1 (en) 2012-07-05
US20120172327A1 (en) 2012-07-05
US20180133235A1 (en) 2018-05-17
CN103369974A (zh) 2013-10-23
CN108420076A (zh) 2018-08-21
US11197875B2 (en) 2021-12-14
US20180169121A1 (en) 2018-06-21
US11654156B2 (en) 2023-05-23
US11633412B2 (en) 2023-04-25
MY166945A (en) 2018-07-25
US20210077512A1 (en) 2021-03-18
EP2658400A2 (en) 2013-11-06
US11975014B2 (en) 2024-05-07
WO2012092157A3 (en) 2012-08-30
MY192208A (en) 2022-08-08
US20210228603A1 (en) 2021-07-29
WO2012092157A2 (en) 2012-07-05
US11464793B2 (en) 2022-10-11
US8703737B2 (en) 2014-04-22
US20180055864A1 (en) 2018-03-01
US20180133234A1 (en) 2018-05-17

Similar Documents

Publication Publication Date Title
MX352040B (es) Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas.
PH12017500874A1 (en) Human milk oligosaccharides for modulating inflammation
MX338174B (es) Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
MY174541A (en) Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MX2020010780A (es) Métodos para disminuir la incidencia de la enterocolitis necrotizante en bebés, infantes, o niños al usar los oligosacáridos de leche humana.
MX343983B (es) Productos nutricionales que incluyen monoglicéridos y ácidos grasos.
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MX2018005297A (es) Formula pediatrica sintetica para estimular celulas nerviosas entericas en el tracto gastrointestinal.
MX356184B (es) Fórmulación pediátrica sintética que comprende un probiótico.
MX2021014138A (es) Metodos para usar los oligosacaridos de leche humana para mejorar la salud respiratoria de las vias aereas.
PH12016500763A1 (en) Synthetic milk compositions comprising polyunsaturated fatty acids (pufas) for promoting the healthy establishment of cognitive function in male and female infant and children
MX2014000895A (es) Galacto-oligosacaridos para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
PH12017500873A1 (en) Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides

Legal Events

Date Code Title Description
FG Grant or registration